| 1 |
A combined inactivated cholera and hepatitis A vaccine-induced potent protective immunity in a mouse model |
|
|
| Nourhan H. AbdelAllah, Ahmed F. Azmy, Mohamed E. Rashed, Sameh AbdelGhani, Yasser Gaber |
|
| Applied Microbiology and Biotechnology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Separation of three strains of polio virus by capillary zone electrophoresis and study of their interaction with aluminum oxyhydroxide. |
|
|
| Camille Malburet, Laurent Leclercq, Jean-François Cotte, Jérôme Thiebaud, Hervé Cottet |
|
| Journal of Chromatography A. 2022; : 462838 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Proposal for the revision of guidelines for clinical trials of vaccines to prevent infectious diseases in Japan |
|
|
| Yumiko Nomura, Kiyohito Noda, Yuusuke Oohashi, Shin Okuda, Jun Matsumoto, Takashi Nakano, Nao Tsuchida, Ken J. Ishii, Kunihiko Hayashi, Tatsuo Iiyama, Hiroshi Onodera, Koji Ishii, Mayumi Shikano, Nobuhiko Okabe |
|
| Vaccine. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China |
|
|
| Xuejiao Pan, Huakun Lv, Hui Liang, Ying Wang, Linzhi Shen, Fuxing Chen, Yaping Chen, Yu Hu |
|
| Human Vaccines & Immunotherapeutics. 2022; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Theories-based determinants analysis of Hib-combined vaccine hesitancy in China: A multi-group structural equation modeling |
|
|
| Xuewen Jiang, Junfen Lin, Wei Wang, Yanrong Zhao, Yinwei Qiu |
|
| Human Vaccines & Immunotherapeutics. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months |
|
|
| Hitt Sharma, Sanjay Lalwani, Sameer Parekh, Pramod Pujari, Sunil Shewale, Sonali Palkar, Neeta Hanumante, Shilpa Gokhale, Jaganathan KS, Rakesh Kumar, Inderjit Sharma, Sunil Gairola |
|
| Human Vaccines & Immunotherapeutics. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference |
|
|
| Md Taufiqul Islam, Kashmira Date, Ashraful Islam Khan, Taufiqur Rahman Bhuiyan, Zahid Hasan Khan, Shamim Ahmed, Motaher Hossain, Fatema Khaton, K Zaman, Nigel A J McMillan, Abhijeet Anand, Qian An, Chenhua Zhang, William C Weldon, Alexander Yu, Stephen Luby, Firdausi Qadri |
|
| Clinical Infectious Diseases. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Improving Innovation and Access to Combination Vaccines for Childhood Immunization in China |
|
|
| Jiyan Ma, Zhuo Li, Yinuo Sun, Zuokun Liu, Yuan Dang, Yangmu Huang |
|
| International Journal of Environmental Research and Public Health. 2022; 19(23): 15557 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Peculiarities of Zika Immunity and Vaccine Development: Lessons from Dengue and the Contribution from Controlled Human Infection Model |
|
|
| Helton C. Santiago, Tertuliano A. Pereira-Neto, Marcela H. Gonçalves-Pereira, Ana C. B. Terzian, Anna P. Durbin |
|
| Pathogens. 2022; 11(3): 294 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy |
|
|
| Alexander Domnich, Andrea Orsi, Carlo-Simone Trombetta, Giulia Guarona, Donatella Panatto, Giancarlo Icardi |
|
| Pharmaceuticals. 2022; 15(3): 322 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Age Structured Mathematical Modeling Studies on COVID-19 with respect to Combined Vaccination and Medical Treatment Strategies |
|
|
| Bishal Chhetri, D. K. K. Vamsi, D. Bhanu Prakash, S. Balasubramanian, Carani B. Sanjeevi |
|
| Computational and Mathematical Biophysics. 2022; 10(1): 281 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants |
|
|
| Hye-Kyung Cho, Su Eun Park, Yae-Jean Kim, Dae Sun Jo, Yun-Kyung Kim, Byung-Wook Eun, Taek-Jin Lee, Jina Lee, Hyunju Lee, Ki Hwan Kim, Eun Young Cho, Jong Gyun Ahn, Eun Hwa Choi |
|
| Clinical and Experimental Pediatrics. 2021; 64(12): 602 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
The study of the therapeutic effectiveness of the associated inactivated and subunit vaccines based on Candida albicans and Candida tropicalis fungi |
|
|
| Mykola Rybalkin, Natalia Khokhlenkova, Yuliia Azarenko, Olha Kaliuzhnaia, Illya Podolsky |
|
| Pharmacia. 2021; 68(1): 89 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Life-Course Approach to Vaccination in Bangladesh for Meeting the Health and Health-Related Sustainable Development Goals: A Commentary |
|
|
| Taufiqur Rahman Bhuiyan, Taufiqul Islam, Firdausi Qadri |
|
| The Journal of Infectious Diseases. 2021; 224(Supplement): S749 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Hexavalent vaccines in infants: a systematic literature review and meta-analysis of the solicited local and systemic adverse reactions of two hexavalent vaccines |
|
|
| Piyali Mukherjee, Essè Ifèbi Hervé Akpo, Anastasia Kuznetsova, Markus Knuf, Sven-Arne Silfverdal, Pope Kosalaraksa, Attila Mihalyi |
|
| Expert Review of Vaccines. 2021; 20(3): 319 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Immunogenicity and protection efficacy of enhanced fitness recombinant Salmonella Typhi monovalent and bivalent vaccine strains against acute toxoplasmosis |
|
|
| Fei-Kean Loh, Sheila Nathan, Sek-Chuen Chow, Chee-Mun Fang |
|
| Pathogens and Global Health. 2021; 115(6): 392 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
DTaP combination vaccine use and adherence: A retrospective cohort study |
|
|
| Matthew M. Loiacono, Vitali Pool, Robertus van Aalst |
|
| Vaccine. 2021; 39(7): 1064 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Was Aldo Castellani the inventor of combined and polyvalent vaccines? |
|
|
| Luca Borghi, Elisabetta Riva |
|
| Vaccine. 2021; 39(38): 5442 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Nanotechnology for making a paradigm shift in COVID-19 vaccine |
|
|
| Dibya Sundar Panda |
|
| Clinical Complementary Medicine and Pharmacology. 2021; : 100017 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
Impact of combination MMRV vaccine on first-dose coverage for measles and varicella: a population-based study |
|
|
| Shannon E. MacDonald, Suzanne Tough, Xiaoyan Guo, James D. Kellner |
|
| Journal of Public Health. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines |
|
|
| Paolo Bonanni, Sara Boccalini, Angela Bechini, Ornella Varone, Giulio Matteo, Federica Sandri, Giovanni Gabutti |
|
| Human Vaccines & Immunotherapeutics. 2020; 16(6): 1313 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study |
|
|
| Victor Romanenko, Irina Osipova, Anna Galustyan, Michael Scherbakov, Nathalie Baudson, Déborah Farhi, Luis Anaya, Sherine O. Kuriyakose, Nadia Meyer, Winnie Janssens |
|
| Human Vaccines & Immunotherapeutics. 2020; 16(9): 2265 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countries |
|
|
| Suthira Taychakhoonavudh, Woralak Chumchujan, Raymond Hutubessy, Nathorn Chaiyakunapruk |
|
| Human Vaccines & Immunotherapeutics. 2020; 16(7): 1728 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
Protection against fowl cholera in ducks immunized with a combination vaccine containing live attenuated duck enteritis virus and recombinant outer membrane protein H of Pasteurella multocida |
|
|
| Nisachon Apinda, Boondarika Nambooppha, Amarin Rittipornlertrak, Pallop Tankaew, Veerasak Punyapornwithaya, Venugopal Nair, Takuo Sawada, Nattawooti Sthitmatee |
|
| Avian Pathology. 2020; 49(3): 221 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
Efficacy, safety, and formulation issues of the combined vaccines |
|
|
| Say-yed Hesameddin Tafreshi |
|
| Expert Review of Vaccines. 2020; 19(10): 949 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 26 |
Combined vaccines for prophylaxis of infectious conditions |
|
|
| Pravin Shende, Mansi Waghchaure |
|
| Artificial Cells, Nanomedicine, and Biotechnology. 2019; 47(1): 695 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 27 |
Studies on formulation of a combination heat killed immunogen from diarrheagenic Escherichia coli and Vibrio cholerae in RITARD model |
|
|
| Priyadarshini Mukherjee, Vivek Mondal, Ushasi Bhaumik, Ritam Sinha, Sounak Sarkar, Soma Mitra, Debaki Ranjan Howlader, Suhrid Maiti, Asish Kumar Mukhopadhyay, Shanta Dutta, Hemanta Koley |
|
| Microbes and Infection. 2019; 21(8-9): 368 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 28 |
Dual Plug-and-Display Synthetic Assembly Using Orthogonal Reactive Proteins for Twin Antigen Immunization |
|
|
| Karl D. Brune, Can M. Buldun, Yuanyuan Li, Iona J. Taylor, Florian Brod, Sumi Biswas, Mark Howarth |
|
| Bioconjugate Chemistry. 2017; 28(5): 1544 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 29 |
A Conjugate Vaccine Using Enantiopure Hapten Imparts Superior Nicotine-Binding Capacity |
|
|
| Jonathan W. Lockner, Jenny M. Lively, Karen C. Collins, Janaína C. M. Vendruscolo, Marc R. Azar, Kim D. Janda |
|
| Journal of Medicinal Chemistry. 2015; 58(2): 1005 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 30 |
Preparation and testing of a Haemophilus influenzae Type b/Hepatitis B surface antigen conjugate vaccine |
|
|
| So Jung An, Joo Sung Woo, Myung Hwa Chae, Sudeep Kothari, Rodney Carbis |
|
| Vaccine. 2015; 33(13): 1614 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 31 |
Booster Vaccination: The Role of Reduced Antigen Content Vaccines as a Preschool Booster |
|
|
| Giovanni Gabutti,Cecilia Trucchi,Michele Conversano,Giambattista Zivelonghi,Giorgio Zoppi |
|
| BioMed Research International. 2014; 2014: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 32 |
What can we learn from the microbial ecological interactions associated with polymicrobial diseases? |
|
|
| J.F. Antiabong,W. Boardman,A.S. Ball |
|
| Veterinary Immunology and Immunopathology. 2013; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 33 |
DTaP-IPV-Hep B-Hib vaccine (Hexyon®/Hexacima®): a guide to its use in the primary and booster vaccination of infants and toddlers in Europe |
|
|
| Katherine A. Lyseng-Williamson,Paul L. McCormack |
|
| Drugs & Therapy Perspectives. 2013; 29(11): 329 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 34 |
DTaP-IPV-Hep B-Hib Vaccine (Hexaxim®) |
|
|
| Paul L. McCormack |
|
| Pediatric Drugs. 2013; 15(1): 59 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 35 |
Modern Subunit Vaccines: Development, Components, and Research Opportunities |
|
|
| Peter Michael Moyle,Istvan Toth |
|
| ChemMedChem. 2013; 8(3): 360 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 36 |
Modern Subunit Vaccines: Development, Components, and Research Opportunities |
|
|
| Moyle, P.M. and Toth, I. |
|
| ChemMedChem. 2013; 8(3): 360-376 |
|
| [Pubmed] [Google Scholar] |
|
| 37 |
DTaP-IPV-Hep B-Hib vaccine (Hexaxim®): A review of its use in primary and booster vaccination |
|
|
| McCormack, P.L. |
|
| Pediatric Drugs. 2013; 15(1): 59-70 |
|
| [Pubmed] [Google Scholar] |
|
| 38 |
Perspectives on optimization of vaccination and immunization of ethiopian children/women: What should and can we further do? why and how? |
|
|
| Gebremariam, M.B. |
|
| Ethiopian Medical Journal. 2012; 50(2): 167-184 |
|
| [Pubmed] [Google Scholar] |
|
